Abiopharma

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

BGC Group to Report Second Quarter 2026 Financial Results on July 30, 2026

Ampco-Pittsburgh Corporation Joins US small-cap Russell 2000® Index

Synchrony Announces Executive Leadership Changes to Advance Digital Growth, Customer Experience and AI Momentum

BXP to Release Second Quarter 2026 Financial Results on July 28, 2026

Frontdoor Names Finance and Real Estate Executive Hilla Sferruzza to Board of Directors

American Coastal Insurance Corporation Announces the Completion of $14.4 Million in Common Stock Share Repurchases

XPO Schedules Second Quarter 2026 Earnings Conference Call for Thursday, July 30, 2026

Results of Operations for the Three Months Ended March 31, 2026 - American Overseas Group Limited Announces Net Income Of $3.3 Million For the Three Months Ended March 31, 2026

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease